Abstract Background: The MelanomAIX project developed an AI-based framework to identify image-derived digital biomarkers predictive of immunotherapy response in malignant melanoma. Histopathological slides contain rich subvisual information that reflects tumor-immune interactions often missed by conventional assessment. By combining deep learning-based tissue characterization with molecular and clinical data, MelanomAIX leverages routine pathology for biomarker discovery and precision oncology. Methods: A real-world cohort of 200 melanoma patients was assembled from multiple clinical archives. Each case was curated with digitized H Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 1454.
Building similarity graph...
Analyzing shared references across papers
Loading...
Koehler et al. (Fri,) studied this question.
www.synapsesocial.com/papers/69d1fceba79560c99a0a2aa3 — DOI: https://doi.org/10.1158/1538-7445.am2026-1454
Theresa Koehler
Eleftherios Mylonakis
Raluca Wroblewski
Cancer Research
Asklepios Kliniken Hamburg
Institut für Hämatopathologie Hamburg
Hamburg Port Consulting (Germany)
Building similarity graph...
Analyzing shared references across papers
Loading...